Clinical trial Recruiting at 1 site Phase 1 Interventional Ages 18 to 75

Saleh's technique: injecting Histoacryl glue into the pancreas during pancreaticojejunostomy

Official title: Pancreatic Parenchymal Injection of N-Butyl-2-Cyanoacrylate for Pancreaticojejunostomy After Pancreaticoduodenectomy: A Novel Technique

Run by Minia University · NCT07132541 · Data updated 2026-11-12

This procedure will try injecting a tissue glue (Histoacryl) into the pancreas during pancreaticoduodenectomy to see if it reduces pancreatic leaks in people with a soft pancreas and a small pancreatic duct.

More Pancreas Cancer trials

Quick facts

PhasePhase 1
Study typeInterventional
Ages18 Years to 75 Years
SexAll
Enrollment30 (estimated)
SponsorMinia University
Academic / other
Locations1 site (Minya, Minya Governorate)
StatusRecruiting
StartedAugust 25, 2025
Main results expectedNovember 25, 2026
Study endsDecember 25, 2026
Registry record updatedSeptember 11, 2026
Trial IDNCT07132541 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are patients planned for pancreaticoduodenectomy for curative-intent malignancy who have a soft pancreatic texture, a main pancreatic duct diameter under 3 mm, and can provide informed consent.

Probably not a fit

Patients with a hard or fibrotic pancreas, large pancreatic ducts, active infection, uncontrolled coagulopathy, distant metastases, or who are unfit for surgery are not candidates and are unlikely to benefit from this technique.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This Phase 1 interventional study injects N-butyl-2-cyanoacrylate (Histoacryl) into the pancreatic parenchyma at the time of pancreaticojejunostomy in patients undergoing pancreaticoduodenectomy who have a soft pancreas and a main duct under 3 mm. Thirty consecutive patients having curative-intent resection for pancreatic, periampullary, cholangiocarcinoma, or duodenal cancer will be enrolled at Minia University between July 2025 and July 2026. The trial's primary focus is safety and feasibility, with systematic collection of preoperative, intraoperative, and postoperative data and monitoring for clinically relevant postoperative pancreatic fistula (POPF) and other complications. Secondary observations include preservation of exocrine drainage, technical performance of parenchymal injection, and rates of parenchymal leakage.

Why it matters

Potential benefit: If successful, the technique could lower clinically significant postoperative pancreatic fistula rates and the complications that follow after pancreaticoduodenectomy.

How similar studies have gone: Use of cyanoacrylate and other tissue adhesives to reinforce pancreatic anastomoses is relatively novel with only limited case series and no large randomized trials demonstrating clear benefit to date.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients undergoing pancreaticoduodenectomy for malignant lesions meeting the curative treatment intent in accordance with clinical guidelines.
* Soft pancreatic texture.
* Small main pancreatic duct diameter (\<3 mm).
* Informed consent obtained.

Exclusion Criteria:

* Known hypersensitivity to cyanoacrylate or Lipiodol®.
* Extremely hard, fibrotic pancreas.
* Significant pancreatitis involving the pancreatic remnant.
* Active infection at the surgical site.
* Uncontrolled coagulopathy.
* Unfit patients for surgery due to severe medical illness.
* Inoperable patients with distant metastases, including peritoneal, liver, distant lymph node metastases, and involvement of other organs.
* Irresectable tumors in diagnostic laparoscopy.
* Patients requiring left, central or total pancreatectomy or other palliative surgery.
* Pregnant or breastfeeding women.
* Patients with serious mental disorders.
* Patients with vascular invasion and requiring vascular resection.
* Patients refused to participate in the study.

Where it's running

  • Liver and GIT hospital , Minia University
    Minya, Minya Governorate, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.